This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase II, multicenter, single-arm study of MPDL3...
Clinical trial

A phase II, multicenter, single-arm study of MPDL3280a in patients with PD-L1-positive locally advanced or metastatic Non-Small Cell Lung Cancer

Read time: 1 mins
Last updated:19th Sep 2013
The primary efficacy objective for this study is to evaluate the efficacy of MPDL3280A in patients with PD-L1?positive locally advanced or metastatic NSCLC, as measured by investigator-assessed ORR according to modified RECIST
Category Value
Study start date 2013-09-19

View full details